TY - JOUR
T1 - Acute Q fever as a cause of acute febrile illness of unknown origin in Taiwan
T2 - Report of seven cases
AU - Ko, Wen Chien
AU - Liu, Jien Wei
AU - Chuang, Yin Ching
PY - 1997/4
Y1 - 1997/4
N2 - Acute Q fever, caused by Coxiella burnetii has been well documented in Western countries, but only recently identified in Taiwan. Seven cases diagnosed by indirect fluorescent antibodies to phase II antigens of C. burnetii are reported. The patients were all men and a history of animal contact could be traced in most cases. Clinical manifestations were high fever, chills, relative bradycardia and elevated serum aminotransferases. Therapy with tetracycline or clarithromycin resulted in defervescence within 96 hours. Combining the knowledge on the prevalence of Q fever in Taiwan, the typical exposure history and clinical features in acute Q fever infection, primary care physicians may be able to avoid invasive but futile diagnostic intervention for patients with prolonged febrile illness. Prior to results from serologic testing, empiric therapy with tetracycline or its analogs may be considered for patients with typical clinical manifestations.
AB - Acute Q fever, caused by Coxiella burnetii has been well documented in Western countries, but only recently identified in Taiwan. Seven cases diagnosed by indirect fluorescent antibodies to phase II antigens of C. burnetii are reported. The patients were all men and a history of animal contact could be traced in most cases. Clinical manifestations were high fever, chills, relative bradycardia and elevated serum aminotransferases. Therapy with tetracycline or clarithromycin resulted in defervescence within 96 hours. Combining the knowledge on the prevalence of Q fever in Taiwan, the typical exposure history and clinical features in acute Q fever infection, primary care physicians may be able to avoid invasive but futile diagnostic intervention for patients with prolonged febrile illness. Prior to results from serologic testing, empiric therapy with tetracycline or its analogs may be considered for patients with typical clinical manifestations.
UR - http://www.scopus.com/inward/record.url?scp=0030974695&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030974695&partnerID=8YFLogxK
M3 - Article
C2 - 9136520
AN - SCOPUS:0030974695
SN - 0929-6646
VL - 96
SP - 295
EP - 297
JO - Journal of the Formosan Medical Association
JF - Journal of the Formosan Medical Association
IS - 4
ER -